Figure 3From: The combined expression of the stromal markers fibronectin and SPARC improves the prediction of survival in diffuse large B-cell lymphoma Kaplan-Meier analysis showing overall survival of 173 DLBCL cases separated on the basis of their expression of fibronectin (A), p = 0.05, SPARC (B), p = 0.083 and combined FN1 high/SPARC high expression (C), p = 0.002. Back to article page